Acadian Asset Management LLC Alpine Immune Sciences, Inc. Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$8.19 - $11.31 $550,007 - $759,534	-67,156 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$8.81 - $15.03 $163,998 - $279,783	18,615 Added 38.35%	67,156 $604,000
Q1 2021 May 11, 2021	BUY	$10.02 - $13.92 $459,897 - $638,900	45,898 Added 1736.59%	48,541 $515,000
Q4 2020 Feb 11, 2021	BUY	$7.42 - $15.96 $19,611 - $42,182	2,643 New	2,643 $33,000
Q1 2019 May 09, 2019	SELL	$4.09 - $7.19 $14,625 - $25,711	-3,576 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$5.68 - $8.59 $6,543 - $9,895	1,152 Added 47.52%	3,576 $22,000
Q2 2018 Jul 24, 2018	BUY	$7.16 - $10.05 $17,355 - $24,361	2,424 New	2,424 $18,000
Q4 2017 Jan 18, 2018	SELL	$9.65 - $12.65 $21,857 - $28,652	-2,265 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$8.0 - $11.6 $18,120 - $26,274	2,265	2,265 $26,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.